Bipolar Disorder Trial, Recruiting NCT05480826 Sponsor: Fondation FondaMental Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT05480826
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • People who have been diagnosed with bipolar disorder, unipolar depression, schizophrenia, or autism spectrum disorder (based on recognised diagnostic standards called DSM IV criteria)
  • People aged 18 or older
  • People enrolled in the French social security system
  • People who are under legal guardianship or a similar form of legal protection (called curatorship) are also eligible
  • People already participating in the Fondation FondaMental research group whose genetic results have shown a need for further genetic comparison and study
  • People who have signed the study consent form

For family members of patients:

  • People aged 18 or older who are a relative of a patient already participating in the Fondation FondaMental research group
  • People enrolled in the French social security system
  • People under legal guardianship or a similar form of legal protection (curatorship) are also eligible
  • People who have signed the study consent form

Who may not be able to join:

  • People whose overall health or circumstances, in the judgment of the trial doctor, would make participation unsuitable or make it difficult to follow the study requirements
  • People who are currently detained or imprisoned
  • People who are unable to understand French

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marion Leboyer, MD PhD, Fondation FondaMental

Phone: 149813775

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondation FondaMental
Registry
ClinicalTrials.gov
Start date
15 March 2023
Est. completion
15 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Measure of the probability of having a psychiatric disorder given the presence of the genetic variant studied.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov